Article

Poll: The Top 5 Non–COVID-19 News Stories in 2020

Answer our poll: What do you think was the top non–COVID-19 story in 2020?

The following stories were the most-read news stories on AJMC.com in 2020 that were not related to the coronavirus disease 2019 (COVID-19) pandemic.

FDA's Revised Blood Donation Guidance for Gay Men Still Courts Controversy
FDA Recalls All Ranitidine (Zantac) Products, Citing Increased Risk of Cancer
Fish Oil Debate Continues as Study Finds No Risk Reduction From Omega-3 Combo
FDA Steps Up Warning for Montelukast for Risk of Mental Health Side Effects
Review of Ketamine in ED for Acute Pain Finds Similar Efficacy to Other Pain Relief

Answer our poll by making a choice below – which do you think was the top non–COVID-19 story in 2020?

FDA's Revised Blood Donation Guidance for Gay Men Still Courts Controversy
FDA Recalls All Ranitidine (Zantac) Products, Citing Increased Risk of Cancer
Fish Oil Debate Continues as Study Finds No Risk Reduction From Omega-3 Combo
FDA Steps Up Warning for Montelukast for Risk of Mental Health Side Effects
Review of Ketamine in ED for Acute Pain Finds Similar Efficacy to Other Pain Relief

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
1 expert is featured in this series.
Miriam Freimer, MD
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Related Content
The mean percent change in body weight from the obesity cohort from baseline to 52 weeks ranged from −12.3% to −16.2% to −16.2%. | Image Credit: ricka_kinamoto - stock.adobe.com
July 1st 2025

Weight-Loss Drug Maridebart Cafraglutide Shows Efficacy in Phase 2 Trial

Sabrina McCrear
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.
Managed Care Cast
June 24th 2025

Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care

Giuliana Grossi Skylar Jeremias Eva Szigethy, MD, PhD Benjamin Cohen, MD
Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.
Outside of patient diversity, the researchers call for variety in data types to strengthen AI models, with a compilation of patient records with genomic data and images. | Image credit: natali_mis - stock.adobe.com
July 1st 2025

Challenges and Opportunities for AI in Melanoma Detection

AJMC Contributor
While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined challenges with these novel approaches.
Logo for Managed Care Cast
June 19th 2025

Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

Maggie L. Shaw Colin Banas, MD, MHA
Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Patients with RS-negative low-risk MDS who were relapsed or refractory to or ineligible for ESAs appeared to experience clinical benefit with imetelstat treatment in a post hoc analysis. | Image credit: fotogurmespb - stock.adobe.com
July 1st 2025

Imetelstat Shows Benefit in RS-Negative, Lower-Risk MDS

Ashley Chan
Imetelstat demonstrated clinical benefits in patients with ring sideroblast–negative lower-risk MDS, according to a post hoc analysis.
emergency department | Image Credit: chrisdorney - stock.adobe.com
June 30th 2025

Prolonged ED Stays, Boarding Times Among Older Adults Underscore Systemic Hospital Strain

Brooke McCormick
The recent increase in prolonged emergency department (ED) stays and boarding times for older adults reveals systemic challenges in US hospital care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo